Next Generation in Anti-Aging Formulas: De-Nouveau by Elan Vital Strikes the Fountain of Youth with the Enzyme Telomerase

September 2, 2010

PALM SPRINGS, Calif., Sept. 2 /PRNewswire/ — Scientists at Elan Vital Pharmaceuticals announce anti-aging technology applications to a new product, De-Nouveau. De-Nouveau utilizes the Nobel Prize-winning discovery of the enzyme telomerase to change the anti-aging product market.

Telomerase allows cellular DNA to recombine the same way a young person’s DNA does. De-Nouveau by Elan Vital re-introduces the telomerase enzyme into the body to dramatically slow down the signs of aging.

De-Nouveau by Elan Vital, a formula created from all natural biological materials, is one of the first products on the market possessing telomerase. Reported results from users show dramatic changes such as increased Collagen production, glowing smooth and shining skin, decreased wrinkles and crows feet, smaller pore size and improved tone and clarity of skin throughout the entire body.

De-Nouveau by Elan Vital is available online at http://www.ElanVitalOnline.com. For a limited time, during this Press Release and Promotion, new customers will receive $100 off the retail price for the six (6) months reset formula De-Nouveau through October 15, 2010. Use Promotion code: 12835.

About Elan Vital

Elan Vital is a privately owned company with headquarters in New Zealand and US offices in Palm Springs, San Diego and Reno, Nevada. Elan Vital Pharmaceuticals researches, develops and produces new technologies in the anti-aging market. Elan Vital products have not been evaluated or approved by the FDA. Elan Vital Pharmaceuticals ships worldwide and their products may only be obtained through ElanVitalOnline.com or through its authorized distributors. For more information on becoming an authorized distributor, please email us at pr@elanvitalonline.com or media@elanvitalonline.com; visit http://www.elanvitalonline.com or call 800-280-9790.

    Kim Gillespie

This press release was issued through eReleases(R). For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

SOURCE Elan Vital Pharmaceuticals

Source: newswire

comments powered by Disqus